


Advent France Biotechnology appoints Alejo Chorny, PhD, as operating partner and head of new Spanish operations

Advent France Biotechnology participe au tour de table de Série B de 74M$ (61,5M€) d’AgomAb Therapeutics

Advent France Biotechnology crée Gamut Therapeutics et finance son amorçage

Advent France Biotechnology appoints Geoffroy de Ribains as operating partner
